[Federal Register Volume 61, Number 154 (Thursday, August 8, 1996)]
[Notices]
[Pages 41427-41428]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-20163]


-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec. 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on April 16, 1996, U.S. Drug 
Testing, Inc., 10410 Trademark Street, Rancho Cucamonga, California 
91730, made application, which was received for processing on June 20, 
1996, to the Drug Enforcement Administration (DEA) for registration as 
a bulk manufacturer of the basic classes of controlled substances 
listed below:

------------------------------------------------------------------------
                   Drug:                               Schedule         
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)...............  I                          
Heroin (9200)..............................  I                          
Amphetamine (1100).........................  II                         
Methamphetamine (1105).....................  II                         
Phencyclidine (7471).......................  II                         
1-Piperidinocyclohexanecarbonitrile (8603).  II                         
Benzoylecgonine (9180).....................  II                         
Morphine...................................  II                         
------------------------------------------------------------------------

    The firm plans to manufacture small quantities of the listed 
controlled substances to make drug test kits.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than October 7, 1996.


[[Page 41428]]


    Dated: July 31, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 96-20163 Filed 8-7-96; 8:45 am]
BILLING CODE 4410-09-M